KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Other Operating Expenses (2016 - 2025)

Merck (MRK) has disclosed Other Operating Expenses for 16 consecutive years, with $9.7 billion as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses rose 145.74% to $9.7 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.3 billion through Dec 2025, up 33.65% year-over-year, with the annual reading at $16.5 billion for FY2025, 8.99% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $9.7 billion at Merck, up from $3.6 billion in the prior quarter.
  • The five-year high for Other Operating Expenses was $9.7 billion in Q4 2025, with the low at $2.7 billion in Q1 2021.
  • Average Other Operating Expenses over 5 years is $4.4 billion, with a median of $3.9 billion recorded in 2022.
  • The sharpest move saw Other Operating Expenses crashed 51.28% in 2024, then skyrocketed 145.74% in 2025.
  • Over 5 years, Other Operating Expenses stood at $3.5 billion in 2021, then grew by 7.51% to $3.8 billion in 2022, then surged by 113.27% to $8.1 billion in 2023, then tumbled by 51.28% to $4.0 billion in 2024, then surged by 145.74% to $9.7 billion in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $9.7 billion, $3.6 billion, and $3.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.